Annual Drug Patent Expirations for LICART
Licart is a drug marketed by Ibsa Inst Bio and is included in one NDA.
The generic ingredient in LICART is diclofenac epolamine. Additional details are available on the diclofenac epolamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
